Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Pituitary FSH is released by a heterodimer of the β-subunits from the two forms of inhibin

Abstract

Inhibin is a gonadal protein that specifically inhibits the secretion of pituitary follicle-stimulating hormone (FSH). Two forms of inhibin (A and B) have been purified from porcine follicular fluid1 and characterized as heterodimers of relative molecular mass (Mr) 32,000 (ref. 2). Each inhibin is comprised of an identical α-subunit of Mr 18,000 and a distinct but related β-subunit of Mr 13,800–14,700 linked by interchain disulphide bond(s). Throughout the purification of inhibins, we consistently observed two fractions which stimulated the secretion of pituitary FSH. We report here the isolation of one of the FSH-releasing proteins; it has a Mr of 24,000 and its N-terminal sequences up to residue 32 are identical to those of each β-subunit of inhibins A and B. In the presence of reducing agents, SDS-polyacrylamide gel electrophoresis resolves the FSH-releasing substance into two subunits which are identical in their migration behaviour to the reduced β-subunits of inhibins A and B. Based on the N-terminal sequence data and Mr of the intact and reduced molecules, we propose that the FSH-releasing substance, which is active in picomolar concentrations, is a heterodimeric protein composed of the two β-subunits of inhibins A and B linked by interchain disulphide bond(s). The structural organization of the FSH-releasing substance is homologous to that of transforming growth factor-β (TGF-β)3, which also possesses FSH-releasing activity in the same bioassay4. We suggest that the substance be called activin to signify the fact that it has opposite biological effects to inhibin.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Ling, N. et al. Proc. natn. Acad. Sci. U.S.A. 82, 7217–7221 (1985).

    Article  CAS  ADS  Google Scholar 

  2. Mason, A. J. et al. Nature 318, 659–663 (1985).

    Article  CAS  ADS  Google Scholar 

  3. Derynck, R. et al. Nature 316, 701–705 (1985).

    Article  CAS  ADS  Google Scholar 

  4. Ying, S-Y. et al. Biochem. biophys. Res. Commun. 135, 950–956 (1986).

    Article  CAS  Google Scholar 

  5. Docherty, K. & Steiner, D. F. A. Rev. Physiol. 44, 625–638 (1982).

    Article  CAS  Google Scholar 

  6. Waterfield, M. D. et al. Nature 304, 35–39 (1983).

    Article  CAS  ADS  Google Scholar 

  7. Heldin, C. H. et al. Nature 319, 511–514 (1986).

    Article  CAS  ADS  Google Scholar 

  8. Laemmli, U. Nature 227, 680–685 (1970).

    Article  CAS  ADS  Google Scholar 

  9. Esch, F. Analyt. Biochem. 136, 39–47 (1984).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ling, N., Ying, SY., Ueno, N. et al. Pituitary FSH is released by a heterodimer of the β-subunits from the two forms of inhibin. Nature 321, 779–782 (1986). https://doi.org/10.1038/321779a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/321779a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing